Fujirebio Acquires PSG to Boost Biological Material Supply

Fujirebio Holdings, Inc., a global leader in in-vitro diagnostics (IVD), has announced the acquisition of PSG (Proliant Biologicals Japan), a company specializing in the production and supply of high-quality biological materials. The acquisition aims to reinforce Fujirebio’s supply chain and enhance its capabilities in developing and manufacturing diagnostic reagents.

Securing Critical Raw Materials for Diagnostics

Through this acquisition, Fujirebio will gain:

• Direct access to key biological materials used in diagnostic reagent production

• Greater control over quality and sourcing of essential components

• A more resilient and efficient global supply network

This move supports the company’s strategy to expand its in-house capabilities and ensure stable delivery of products amid rising global demand for reliable diagnostic tools.

Enhancing Development and Manufacturing Integration

By incorporating PSG’s production expertise, Fujirebio plans to:

• Accelerate R&D for next-generation diagnostic products

• Improve cost efficiency and production scalability

• Strengthen global competitiveness in IVD technologies

Executive Commentary

A Fujirebio spokesperson commented:
“The acquisition of PSG aligns with our vision of securing a robust, high-quality supply chain that supports both innovation and reliability in diagnostics.”

👉 Read the full analysis at- Fujirebio Acquires PSG to Boost Biological Material Supply

👉 Subscribe us IT Business Today

https://itbusinesstoday.com/